Galderma Group N GALD.SW · Stock Open Galderma Group N in new tab
Analyst price targets
Recent rating changes, newest first
Galderma Group N Analysis (GALD.SW)
Is Galderma Group N a good investment? Galderma Group N (GALD.SW) is currently trading at 173.35 CHF. Market analysts have a consensus price target of 196.32 CHF. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 59.26. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Galderma Group N is expected to release its next earnings report on March 11, 2027. The market consensus estimate for Forward EPS is 5.57.
For income investors, Galderma Group N pays a dividend yield of 0.21%. With a payout ratio of 11%, the dividend appears sustainable.
Investor FAQ
Does Galderma Group N pay a dividend?
Yes, it pays an annual dividend of 0.42 CHF (0.21% yield).
What asset class is Galderma Group N?
Galderma Group N is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be March 11, 2027. The company currently has a trailing EPS of 2.90.
Company Profile
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.35 CHF
|
| April 28, 2027 (estimated) | 0.3500 |
| ▸2026 |
0.35 CHF
|
| April 28, 2026 | 0.3500 |
| ▸2025 |
0.15 CHF
|
| April 29, 2025 | 0.1500 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Galderma Group N | Apr 28, 2026 | Paid | 0.35 CHF |
Community Discussion